| abstract |
The present invention is directed to prodrugs comprising amino acids linked to pharmaceuticals or drugs having hydroxy, amino, carboxy or acylated derivatives. Prodrugs have the same utility as the original drug, but have higher therapeutic properties. Indeed, the prodrugs of the present invention enhance at least two therapeutic attributes, as defined herein. The present invention is also directed to pharmaceutical compositions comprising the prodrug. [Selection] Figure 1 |